1. Chairman's introduction

   • C. Solberg

   EditorialNotes Pages: S357 - S357

2. The scope of lower respiratory tract infection

   • J. H. Winter

   OriginalPaper Pages: S359 - S364

3. Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens

   • C. Chidiac
   • Y. Mouton

   OriginalPaper Pages: S365 - S371

4. Ofloxacin in lower respiratory tract infections

   • W. Petermann

   OriginalPaper Pages: S372 - S377

5. Use of oral Ofloxacin in lower respiratory tract infections

   • W. E. Sanders Jr.

   OriginalPaper Pages: S378 - S379

6. Sequential therapy with I. V. and oral ofloxacin in lower respiratory tract infections: A comparative study

   • H. Feist

   OriginalPaper Pages: S380 - S383

7. Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease

   • A. Watanabe

   OriginalPaper Pages: S384 - S387

8. Double-blind comparative study of ofloxacin (hoe 280) and trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbations of chronic bronchitis and chronic obstructive lung disease

   • N. P. Boye
   • P. Gaustad

   OriginalPaper Pages: S388 - S390

9. Closing remarks

   • V. T. Andriole

   Report Pages: S391 - S392